Gragnano Eduardo, Cocozza Sirio, Rizzuti Michele, Buono Giuseppe, Elefante Andrea, Guida Amedeo, Marseglia Mariano, Tarantino Margherita, Manganelli Fiore, Tortora Fabio, Briganti Francesco
"Federico II" University Hospital, Naples, Italy.
Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
Eur Radiol. 2025 Jul 9. doi: 10.1007/s00330-025-11779-8.
Computed tomography perfusion (CTP) represents one of the main determinants in the decision-making strategy of stroke patients, being very useful in triaging these patients. The aim of this review is to describe the current knowledge and the future applications of AI in CTP. This review contains a short technical description of the CTP technique and how perfusion parameters are currently estimated and applied in clinical practice. We then provided a comprehensive literature review on the performance of CTP analysis software aimed at understanding whether possible differences between commercially available software might have a direct implication on neuroradiological patient stratification, and therefore on their clinical outcomes. An overview of past, present, and future of software used for CTP estimation, with an emphasis on those AI-based, is provided. Finally, future challenges regarding technical aspects and ethical considerations are discussed. In the current state, most of the use of AI in CTP estimation is limited to some technical steps of the processing pipeline, and especially in the correction of motion artifacts, with deconvolution methods that are still widely used to generate CTP-derived variables. Major drawbacks in AI implementation are still present, especially regarding the "black-box" nature of some models, technical workflow implementations, and the economic costs. In the future, the integration of AI with all the information available in clinical practice should fulfill the aim of developing patient-specific CTP maps, which will overcome the current limitations of threshold-based decision-making processes and will lead physicians to better patient selection and earlier and more efficient treatments. KEY POINTS: Question AI is a widely investigated field in neuroradiology, yet no comprehensive review is yet available on its role in CT perfusion (CTP) in stroke patients. Findings AI in CTP is mainly used for motion correction; future integration with clinical data could enable personalized stroke treatment, despite ethical and economic challenges. Clinical relevance To date, AI in CTP mainly finds applications in image motion correction; although some ethical, technical, and vendor standardization issues remain, integrating AI with clinical data in stroke patients promises a possible improvement in patient outcomes.
计算机断层扫描灌注成像(CTP)是卒中患者决策策略的主要决定因素之一,对这些患者的分诊非常有用。本综述的目的是描述人工智能在CTP中的当前知识和未来应用。本综述包含CTP技术的简短技术描述,以及目前灌注参数在临床实践中的估计和应用方式。然后,我们对CTP分析软件的性能进行了全面的文献综述,旨在了解市售软件之间可能存在的差异是否会对神经放射学患者分层产生直接影响,进而影响其临床结局。本文概述了用于CTP估计的软件的过去、现在和未来,重点介绍了基于人工智能的软件。最后,讨论了技术方面和伦理考量的未来挑战。在当前状态下,人工智能在CTP估计中的应用大多限于处理流程的一些技术步骤,尤其是在运动伪影校正方面,反卷积方法仍被广泛用于生成CTP衍生变量。人工智能实施中仍然存在主要缺点,特别是一些模型的“黑箱”性质、技术工作流程实施和经济成本。未来,人工智能与临床实践中所有可用信息的整合应实现开发针对患者的CTP图谱的目标,这将克服当前基于阈值的决策过程的局限性,并引导医生更好地选择患者,实现更早、更有效的治疗。关键点:问题人工智能是神经放射学中一个广泛研究的领域,但尚未有关于其在卒中患者CT灌注成像(CTP)中作用的全面综述。发现CTP中的人工智能主要用于运动校正;尽管存在伦理和经济挑战,但未来与临床数据的整合可能实现个性化的卒中治疗。临床意义迄今为止,CTP中的人工智能主要应用于图像运动校正;尽管仍存在一些伦理、技术和供应商标准化问题,但将人工智能与卒中患者的临床数据整合有望改善患者结局。